Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Cognitive Impairment in Late-life Anxiety Disorders
NCT01333098Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in cognitive impairment, sponsored by Washington University School of Medicine. Started Sep 2012; status: completed.
02
Drugs
mifepristone
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT01333098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333098.